2-Ethylhexyl methoxycinnamate (EHMC) is one of the most used ultraviolet filters in personal care products. It undergoes cis/trans isomerization in sunlight, and there is limited toxicological understanding of the effects of the cis-isomer. It is known that two geometric isomers of one compound can have different physico-chemical properties and effects. However, there are no studies focusing on toxicokinetics of EHMC isomerization products to compare their potential difference in dermal exposure to cis-EHMC and trans-EHMC due to the difference in their dermatotoxicokinetics. In this study, dermal absorption of the parental trans-EHMC and its cis isomer was studied. A commercially available sunscreen lotion containing trans-EHMC and spiked with laboratory-prepared cis-EHMC was locally applied on the forearm skin of two volunteers. After 8 h of skin exposure, the stratum corneum (SC) layer was removed by tape stripping. The removed thickness of the SC was determined spectrophotometrically using a total protein assay. The concentration of both isomers in the removed SC was measured by HPLC-DAD. A new diffusion and permeability coefficient of both EHMC isomers in SC were determined by Fick's second law of diffusion in vivo. The difference in dermatotoxicokinetic parameters between the two isomers was not statistically significant. However, separate toxicological studies of isomeric forms and the determination of their dermatotoxicokinetic parameters are crucial for refinement of human risk assessment.

Faculty of Science RECETOX Research Centre for Toxic Compounds in the Environment Masaryk University Kamenice 753 5 625 00 Brno Czech Republic

Zobrazit více v PubMed

Aquat Toxicol. 2006 Oct 12;79(4):305-24 PubMed

Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):94-8 PubMed

Skin Pharmacol Appl Skin Physiol. 2003 Jan-Feb;16(1):28-35 PubMed

Exp Clin Endocrinol Diabetes. 2010 May;118(5):298-303 PubMed

Int J Pharm. 2015 Jan 30;478(2):804-10 PubMed

J Invest Dermatol. 1973 Jul;61(1):30-2 PubMed

Xenobiotica. 1992 Aug;22(8):983-91 PubMed

Skin Pharmacol Physiol. 2008;21(1):23-9 PubMed

Skin Pharmacol Appl Skin Physiol. 2000 Nov-Dec;13(6):336-44 PubMed

Int J Mol Sci. 2015 Mar 27;16(4):6960-77 PubMed

J Invest Dermatol. 1988 Jul;91(1):56-61 PubMed

Skin Pharmacol Physiol. 2004 Jan-Feb;17(1):17-22 PubMed

Int J Pharm. 2015 Aug 1;491(1-2):162-9 PubMed

Arch Biochem Biophys. 2006 Jan 1;445(1):115-23 PubMed

Water Res. 2014 Apr 15;53:58-67 PubMed

Anal Bioanal Chem. 2009 Nov;395(5):1513-24 PubMed

Sci Total Environ. 2016 Dec 1;572:1092-1100 PubMed

Environ Int. 2015 Jan;74:249-57 PubMed

Immunopharmacol Immunotoxicol. 2006;28(3):501-10 PubMed

Acta Derm Venereol. 2003;83(6):410-3 PubMed

Arch Dermatol. 1963 Dec;88:702-5 PubMed

Toxicol Sci. 2005 Feb;83(2):264-72 PubMed

Int J Cosmet Sci. 2001 Jun;23(3):153-60 PubMed

Photochem Photobiol Sci. 2015 Sep 26;14(9):1607-16 PubMed

Pharm Res. 2012 Aug;29(8):2035-46 PubMed

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:80-7 PubMed

Anesthesiology. 1994 Jun;80(6):1296-302 PubMed

Pharm Res. 1996 May;13(5):770-4 PubMed

J Invest Dermatol. 2004 Jul;123(1):57-61 PubMed

Chemosphere. 2010 Nov;81(10):1171-83 PubMed

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):850-60 PubMed

Toxicol Appl Pharmacol. 2011 Feb 1;250(3):278-90 PubMed

J Agric Food Chem. 1981 Jan-Feb;29(1):130-5 PubMed

Int J Pharm. 2005 Mar 23;292(1-2):187-94 PubMed

AMA Arch Derm. 1956 Jul;74(1):46-9 PubMed

PLoS One. 2014 Feb 26;9(2):e88517 PubMed

Lancet. 1997 Sep 20;350(9081):863-4 PubMed

Fed Regist. 1999 May 21;64(98):27666-93 PubMed

Pharmazie. 2013 Jan;68(1):34-40 PubMed

Br J Dermatol. 2007 Feb;156(2):231-40 PubMed

Int J Cosmet Sci. 2016 Jun;38(3):224-31 PubMed

J Biol Chem. 1951 Nov;193(1):265-75 PubMed

Biochem Pharmacol. 2006 Feb 28;71(5):657-69 PubMed

Sci Total Environ. 2017 Sep 1;593-594:18-26 PubMed

Acta Derm Venereol. 1998 May;78(3):186-9 PubMed

Environ Toxicol. 2017 Feb;32(2):569-580 PubMed

Mutat Res. 1982 Nov;105(5):303-8 PubMed

Skin Pharmacol Physiol. 2011;24(4):182-9 PubMed

Drug Metab Dispos. 2009 Feb;37(2):247-53 PubMed

J Eur Acad Dermatol Venereol. 2008 Apr;22(4):456-61 PubMed

Skin Res Technol. 2005 May;11(2):97-101 PubMed

Eur J Clin Pharmacol. 1992;42(5):539-44 PubMed

Adv Drug Deliv Rev. 2013 Feb;65(2):169-90 PubMed

Eur J Pharm Biopharm. 2009 Jun;72(2):317-23 PubMed